Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats

Te Chao Fang, Wann Chu Huang

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The study was conducted to examine the effects of the angiotensin subtype 1 and 2 receptor antagonists (losartan and PD123319, respectively) on blood pressure (BP) and renal excretory function in chronic hyperinsulinemia- induced hypertension in rats. Hyperinsulinemia was achieved by insulin infusion (21.5 pmol/kg per minute) via osmotic minipump for 6 weeks. Losartan or PD 123319 was coinfused either at the beginning or after 4 weeks of insulin infusion. The results showed that insulin infusion significantly increased the plasma insulin concentration from 259.0±22.2 to 646.5±33.0 and 713.9±26.5 pmol/L (P

Original languageEnglish
Pages (from-to)235-242
Number of pages8
JournalHypertension
Volume32
Issue number2
Publication statusPublished - Aug 1998
Externally publishedYes

Fingerprint

Angiotensin Receptors
Hyperinsulinism
Insulin
Hypertension
Losartan
Angiotensins
Blood Pressure
Kidney
PD 123319

Keywords

  • Angiotensin receptor antagonist
  • Hyperinsulinemia
  • Insulin resistance
  • Losartan
  • PD123319

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats. / Fang, Te Chao; Huang, Wann Chu.

In: Hypertension, Vol. 32, No. 2, 08.1998, p. 235-242.

Research output: Contribution to journalArticle

@article{614ec10db8904a35bdafccb358e68de5,
title = "Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats",
abstract = "The study was conducted to examine the effects of the angiotensin subtype 1 and 2 receptor antagonists (losartan and PD123319, respectively) on blood pressure (BP) and renal excretory function in chronic hyperinsulinemia- induced hypertension in rats. Hyperinsulinemia was achieved by insulin infusion (21.5 pmol/kg per minute) via osmotic minipump for 6 weeks. Losartan or PD 123319 was coinfused either at the beginning or after 4 weeks of insulin infusion. The results showed that insulin infusion significantly increased the plasma insulin concentration from 259.0±22.2 to 646.5±33.0 and 713.9±26.5 pmol/L (P",
keywords = "Angiotensin receptor antagonist, Hyperinsulinemia, Insulin resistance, Losartan, PD123319",
author = "Fang, {Te Chao} and Huang, {Wann Chu}",
year = "1998",
month = "8",
language = "English",
volume = "32",
pages = "235--242",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats

AU - Fang, Te Chao

AU - Huang, Wann Chu

PY - 1998/8

Y1 - 1998/8

N2 - The study was conducted to examine the effects of the angiotensin subtype 1 and 2 receptor antagonists (losartan and PD123319, respectively) on blood pressure (BP) and renal excretory function in chronic hyperinsulinemia- induced hypertension in rats. Hyperinsulinemia was achieved by insulin infusion (21.5 pmol/kg per minute) via osmotic minipump for 6 weeks. Losartan or PD 123319 was coinfused either at the beginning or after 4 weeks of insulin infusion. The results showed that insulin infusion significantly increased the plasma insulin concentration from 259.0±22.2 to 646.5±33.0 and 713.9±26.5 pmol/L (P

AB - The study was conducted to examine the effects of the angiotensin subtype 1 and 2 receptor antagonists (losartan and PD123319, respectively) on blood pressure (BP) and renal excretory function in chronic hyperinsulinemia- induced hypertension in rats. Hyperinsulinemia was achieved by insulin infusion (21.5 pmol/kg per minute) via osmotic minipump for 6 weeks. Losartan or PD 123319 was coinfused either at the beginning or after 4 weeks of insulin infusion. The results showed that insulin infusion significantly increased the plasma insulin concentration from 259.0±22.2 to 646.5±33.0 and 713.9±26.5 pmol/L (P

KW - Angiotensin receptor antagonist

KW - Hyperinsulinemia

KW - Insulin resistance

KW - Losartan

KW - PD123319

UR - http://www.scopus.com/inward/record.url?scp=0031845973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031845973&partnerID=8YFLogxK

M3 - Article

C2 - 9719048

AN - SCOPUS:0031845973

VL - 32

SP - 235

EP - 242

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -